Logo image of QPT.CA

QUEST PHARMATECH INC (QPT.CA) Stock Fundamental Analysis

TSX-V:QPT - TSX Venture Exchange - CA74836M1068 - Common Stock - Currency: CAD

0.03  +0 (+20%)

Fundamental Rating

2

Overall QPT gets a fundamental rating of 2 out of 10. We evaluated QPT against 23 industry peers in the Biotechnology industry. Both the profitability and financial health of QPT have multiple concerns. QPT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year QPT was profitable.
QPT had a negative operating cash flow in the past year.
QPT had negative earnings in 4 of the past 5 years.
In the past 5 years QPT always reported negative operating cash flow.
QPT.CA Yearly Net Income VS EBIT VS OCF VS FCFQPT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

QPT has a better Return On Assets (59.39%) than 100.00% of its industry peers.
QPT has a better Return On Equity (62.17%) than 100.00% of its industry peers.
Industry RankSector Rank
ROA 59.39%
ROE 62.17%
ROIC N/A
ROA(3y)-115.95%
ROA(5y)-75.7%
ROE(3y)-119.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QPT.CA Yearly ROA, ROE, ROICQPT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

QPT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QPT.CA Yearly Profit, Operating, Gross MarginsQPT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50K -100K -150K

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, QPT has about the same amount of shares outstanding.
The number of shares outstanding for QPT has been increased compared to 5 years ago.
QPT has a worse debt/assets ratio than last year.
QPT.CA Yearly Shares OutstandingQPT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
QPT.CA Yearly Total Debt VS Total AssetsQPT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

QPT has an Altman-Z score of 1.55. This is a bad value and indicates that QPT is not financially healthy and even has some risk of bankruptcy.
QPT has a Altman-Z score of 1.55. This is amongst the best in the industry. QPT outperforms 87.50% of its industry peers.
QPT has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.04, QPT is doing good in the industry, outperforming 79.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 1.55
ROIC/WACCN/A
WACCN/A
QPT.CA Yearly LT Debt VS Equity VS FCFQPT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

QPT has a Current Ratio of 0.31. This is a bad value and indicates that QPT is not financially healthy enough and could expect problems in meeting its short term obligations.
QPT has a Current ratio of 0.31. This is comparable to the rest of the industry: QPT outperforms 41.67% of its industry peers.
QPT has a Quick Ratio of 0.31. This is a bad value and indicates that QPT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.31, QPT perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
QPT.CA Yearly Current Assets VS Current LiabilitesQPT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 231.78% over the past year.
EPS 1Y (TTM)231.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
QPT.CA Yearly Revenue VS EstimatesQPT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
QPT.CA Yearly EPS VS EstimatesQPT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.33 indicates a rather cheap valuation of QPT.
Compared to the rest of the industry, the Price/Earnings ratio of QPT indicates a rather cheap valuation: QPT is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, QPT is valued rather cheaply.
Industry RankSector Rank
PE 0.33
Fwd PE N/A
QPT.CA Price Earnings VS Forward Price EarningsQPT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QPT.CA Per share dataQPT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

QPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUEST PHARMATECH INC

TSX-V:QPT (3/7/2025, 7:00:00 PM)

0.03

+0 (+20%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)12-19 2024-12-19
Earnings (Next)05-27 2025-05-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.27%
Ins Owner ChangeN/A
Market Cap5.07M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.33
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB 0.22
EV/EBITDA N/A
EPS(TTM)0.09
EY300%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 59.39%
ROE 62.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-115.95%
ROA(5y)-75.7%
ROE(3y)-119.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z 1.55
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)231.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-51.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.87%
OCF growth 3YN/A
OCF growth 5YN/A